Aaron H. Burstein
Corporate Officer/Principal chez vTv Therapeutics LLC
Profil
Aaron H.
Burstein is currently a Senior Vice President-Clinical Development at vTv Therapeutics LLC.
Previously, he worked as a Senior Director-Clinical & Developmental at Pfizer Inc. from 2001 to 2012.
He also held the position of Senior Vice President-Clinical Development at VTVX Holdings I LLC and vTv Therapeutics, Inc. Additionally, he worked as an Assistant Professor at the University of Maryland School of Pharmacy from 1995 to 1999 and as a Principal at the National Institute of Health Policy.
Burstein received his undergraduate and doctorate degrees from the State University of New York at Buffalo in 1990 and 1993, respectively.
Postes actifs de Aaron H. Burstein
| Sociétés | Poste | Début |
|---|---|---|
vTv Therapeutics LLC
 vTv Therapeutics LLC Pharmaceuticals: MajorHealth Technology vTv Therapeutics LLC is a clinical-stage biopharmaceutical company which engages in the discovery and development of small molecule drug candidates to fill unmet medical needs. It focuses on treating metabolic diseases to minimize their long-term complications through end-organ protection. The company is headquartered in High Point, NC. | Corporate Officer/Principal | - |
Anciens postes connus de Aaron H. Burstein
| Sociétés | Poste | Fin |
|---|---|---|
| VTV THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01/12/2021 |
| PFIZER, INC. | Corporate Officer/Principal | 01/07/2012 |
| University of Maryland School of Pharmacy | Corporate Officer/Principal | 01/01/1999 |
| National Institute of Health Policy | Corporate Officer/Principal | - |
VTVX Holdings I LLC
 VTVX Holdings I LLC Miscellaneous Commercial ServicesCommercial Services VTVX Holdings I LLC discovers, develops and commercializes human therapeutics to fill unmet medical needs. Its products include a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a range of human diseases, including central nervous system disorders, cardiovascular disorders, type I/II diabetes, obesity, metabolic diseases, inflammatory diseases, female sexual dysfunction, primary open angle glaucoma and cancer. The company was founded in 1998 by Dr. Adnan M. M. Mjalli and is headquartered in High Point, NC. | Corporate Officer/Principal | - |
Formation de Aaron H. Burstein
| State University of New York at Buffalo | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| VTV THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
VTVX Holdings I LLC
VTVX Holdings I LLC Miscellaneous Commercial ServicesCommercial Services VTVX Holdings I LLC discovers, develops and commercializes human therapeutics to fill unmet medical needs. Its products include a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a range of human diseases, including central nervous system disorders, cardiovascular disorders, type I/II diabetes, obesity, metabolic diseases, inflammatory diseases, female sexual dysfunction, primary open angle glaucoma and cancer. The company was founded in 1998 by Dr. Adnan M. M. Mjalli and is headquartered in High Point, NC. | Commercial Services |
| National Institute of Health Policy | |
vTv Therapeutics LLC
vTv Therapeutics LLC Pharmaceuticals: MajorHealth Technology vTv Therapeutics LLC is a clinical-stage biopharmaceutical company which engages in the discovery and development of small molecule drug candidates to fill unmet medical needs. It focuses on treating metabolic diseases to minimize their long-term complications through end-organ protection. The company is headquartered in High Point, NC. | Health Technology |
